Alerts
Want to monitor LGVN?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor LGVNWant to monitor LGVN?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor LGVNLongeveron is a clinical stage biotechnology company developing cellular therapies for specific aging-related and life-threatening conditions. The Company’s lead investigational product is the LOMECEL-B™ cell-based therapy product (“Lomecel-B”), which is derived from culture-expanded medicinal signaling cells (MSCs) that are sourced from bone marrow of young, healthy adult donors. Longeveron believes that by using the same cells that promote tissue repair, organ maintenance, and immune system function, it can develop safe and effective therapies for some of the most difficult disorders associated with the aging process and other medical disorders.